Kyntra Bio Inc (FGEN) Live Share Price, Invest From India

Kyntra Bio Inc Stock Performance

as on January 8, 2026 at 7:59 am IST

Day's Low
Day's High
$9.24
Day's Price Range
$9.75
$9.53
3.04%
Downside
2.31%
Upside
52 Week's Low
52 Week's High
$4.85
52-Week Price Range
$12.60
$9.53
49.11%
Downside
32.21%
Upside

Kyntra Bio Inc share price movements today

Previous Close: $9.02
Open: $9.24
Volume: 345.9K
Day's Low - High: $9.24 - $9.75
52 Week Low - High: $4.85 - $12.60

Kyntra Bio Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Kyntra Bio Inc Stock Fundamentals & Key Indicators

Check Kyntra Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Kyntra Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kyntra Bio Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Kyntra Bio Inc	SELL	$-	NA	NA	0.00%
Insmed Inc	BUY	$30.1B	329.05%	NA	-210.54%
Alnylam Pharmaceuticals Inc	BUY	$40.2B	127.94%	75.85	12.55%
Vertex Pharmaceuticals Inc	BUY	$107.9B	99.08%	25.18	32.94%
Regeneron Pharmaceuticals Inc	BUY	$73.6B	40.83%	17.13	29.65%

Analyst Recommendation on Kyntra Bio Inc Stock

Based on 8 analysts

SELL

0.00%

Buy

37.50%

Hold

62.50%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'SELL' rating for Kyntra Bio Inc. Average target price of $43

Kyntra Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Kyntra Bio Inc.

What analysts predicted

77.84%UPSIDE

Target Price

$43

Current Price

$9.53

Analyzed by

8 Analysts

Target

$43.00

Kyntra Bio Inc target price $43, a slight upside of 77.84% compared to current price of $9.53. According to 8 analysts rating.

Kyntra Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	44	40	27	25	0	46	-123	2	1	1
Gross Profit	38	35	21	-32	-31	41	-102	2	1	1
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-87	-63	-56	-32	-15	-17	17	4	-7	200
Net Profit Margin	-197.84%	-158.51%	-207.21%	-129.84%	-1557.52%	-36.87%	-14.59%	169.37%	-564.02%	18646.47%

Kyntra Bio Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	180	179	125	212	256	176	235	140	46	29
Gross Profit	-33	-7	-70	-22	255	167	222	120	42	14
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-85	-61	-126	-86	-76	-189	-291	-293	-284	-47
Net Profit Margin	-47.44%	-34.35%	-100.43%	-40.58%	-30.00%	-107.36%	-123.68%	-208.66%	-607.29%	-160.63%

Global Institutional Holdings in Kyntra Bio Inc

Funds	Holdings
Bank of America Corp	0.01%
Atlantic Trust Group, LLC	0.01%
Marshall Wace Asset Management Ltd	1.79%
Geode Capital Management, LLC	1.09%
Goldman Sachs Group Inc	0.03%

See all

Insights on Kyntra Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, FGEN stock has moved up by 14.2%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -7.60M → 200.63M (in $), with an average increase of 103.8% per quarter
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 889.3% return, outperforming this stock by 987.3%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 167.8% return, outperforming this stock by 208.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.73M → 1.07M (in $), with an average decrease of 35.5% per quarter

About Kyntra Bio Inc

FibroGen, Inc. is a biopharmaceutical company focused on the development of novel therapies at the frontiers of cancer biology and anemia. It is developing FG-3246, a potential first-in-class antibody-drug conjugate (ADC) targeting CD46, for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and potentially other cancers. This program also includes the development of FG-3180, an associated CD46-targeted positron emission tomography (PET) biomarker and imaging agent. It is also developing Roxadustat, an oral medication, first-in-class, oral small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), which is evaluated for the treatment of anemia in patients with chronic kidney disease (CKD), anemia associated with myelodysplastic syndromes and chemotherapy-induced anemia. Roxadustat is approved in China, Europe, Japan, and numerous other countries for the treatment of anemia of CKD in adult patients on dialysis (DD) and not on dialysis (NDD).

Organisation	Kyntra Bio Inc
E-voting on shares	Click here to vote

FAQs

What is Kyntra Bio Inc share price today?

Kyntra Bio Inc share price today is $9.53 as on January 8, 2026 at 2:29 am IST at the close of the market. Kyntra Bio Inc share today touched a day high of $9.75 and a low of $9.24.

What is the 52 week high and 52 week low for Kyntra Bio Inc share?

Kyntra Bio Inc share touched a 52 week high of $12.6 on September 3, 2025 and a 52 week low of $4.85 on June 30, 2025. Kyntra Bio Inc stock price today i.e. January 8, 2026 at 2:29 am IST is closed at $9.53,which is 24.37% down from its 52 week high and 96.49% up from its 52 week low.

How to invest in Kyntra Bio Inc Stock (FGEN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kyntra Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kyntra Bio Inc Shares that will get you 0.1574 shares as per Kyntra Bio Inc share price of $9.53 per share as on January 8, 2026 at 2:29 am IST.

What is the minimum amount required to buy Kyntra Bio Inc Stock (FGEN) from India?

Indian investors can start investing in Kyntra Bio Inc (FGEN) shares with as little as ₹95.28 or $1 (as of May 6, 2026 at 2:09 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Kyntra Bio Inc stock (as per the Rupee-Dollar exchange rate as on May 6, 2026 at 2:09 pm IST). Based on Kyntra Bio Inc share’s latest price of $9.53 as on January 8, 2026 at 2:29 am IST, you will get 1.0493 shares of Kyntra Bio Inc. Learn more about fractional shares .